MYP_134822
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
9 amino acids
C50H84N10O12S
Standard
Sequence
KVVEFLAML
Physicochemical Analysis
1049.33 Da
6.00
-0.24
-0.44
-0.0265
1.68
0.44
0.50
-0.54
162.22
0.1111
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
359.44
0.69
12.0
13.0
35.0
73.0
1.0
8.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0058183 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
Multiple myeloma(MM); HLA-A*02:01
Cytotoxicity
RECORD: Rec_0114463 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Multiple myeloma(MM); HLA-A*02:01
0.0264 μM
Predicted HLA-I binding
RECORD: Rec_0151862 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
Multiple myeloma(MM); HLA-A*02:01
ELISPOT